| Bilgi: |
Haber Kaynağı: Çeşitli Haber Siteleri
Effectiveness of 2-Dose BNT162b2 (Pfizer BioNTech) mRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5-11 Years and Adolescents Aged 12-15 Years - PROTECT Cohort, July 2021-February 2022
This report describes vaccination with a primary series of the Pfizer-BioNTech mRNA COVID-19 vaccine as effective in protecting against Omicron infection among children and adolescents.
https://tools.cdc.gov/api/embed/downloader/download.asp?m=342778&c=603187
|
